Bangalore: The death of 49 babies in clinical trials at the All India Institute of Medical Sciences (AIIMS) in New Delhi may have opened a Pandora’s box as two of the trial drugs have never been tried on patients below 18 years, an expert said. How many of the children died because of the trial […]
Indian subjects in clinical trials are vulnerable lot
The government of India enacted a new rule that allows foreign pharmaceutical companies and other interested parties to conduct trials of new drugs in India during the same time that trials of the same phase are being conducted in other countries. But even under the new rule, phase 1 trials will not normally be permitted […]
Contract Research Organizations (CROs) in India: A Clinical Approach
Disease has always plagued man. In the 21st century, mankind is confronted with various new afflictions/diseases. This situation poses a challenge to the healthcare sector and the pharmaceutical industry. The need and demand for effective cures for various diseases, hitherto unknown, is testing the limits of science and technology development. These newer diseases further challenge […]
Spreading awareness on the forgetfulness disease – Is there a link between diet & dementia?
Among the several diseases that occur to the elderly people, one of the most serious is dementia as it still has no cure. There are many who still don’t know what dementia is and they wonder what sort of symptoms this disease has. If you too are one among the herd of people who are […]
NYSEMKT:IMUC Investor News: Lawsuit against ImmunoCellular Therapeutics Ltd filed
An investor in NYSEMKT:IMUC shares filed a lawsuit over alleged violations of Federal Securities Laws by ImmunoCellular Therapeutics. Investors who purchased shares of ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The plaintiff claims that between May 1, 2012 through December 11, 2013 the defendants developed […]
Medical Device, Drug Bill Heads to the House
In the final weeks before adjournment, the House will vote on a $6.3-billion bill that would make it easier for medical-device and drug companies to get approval for their products. The bill would also provide money for opioid addiction and biomedical research, according to a report from the Wall Street Journal. The legislation includes provisions […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 29
- Next Page »